If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
150.00    -2.00 (-1.32%)
Bid:
149.50
Ask:
150.10
Spread: 0.60 (0.401%)
Market Cap: £379.33m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Director/PDMR Shareholding

Today 16:40

RNS Number : 2149L
Marshalls PLC
06 July 2026
Β 

Β 

Marshalls plc

(the "Company" or "Marshalls")

Β 

EBT Share Purchase

Β 

The Company has been notified by the Trustee of the Marshalls plc Employee Benefit Trust (the "EBT") that, pursuant to an irrevocable instruction given to the Company's broker, Peel Hunt LLP on 2 July 2026, the EBT has purchased 547,000 ordinary shares of 25 pence each in the Company ("Ordinary Shares") at an average price of 151 pence per share (the "EBT Share Purchase").

Β 

The EBT is a discretionary trust for the benefit of employees of the Company and its subsidiaries, including the Executive Directors of the Company. Shares held in the EBT are used to satisfy awards made pursuant to Marshalls' employee share schemes. The EBT Share Purchase has been funded by a loan provided to the EBT by the Company from its existing cash resources.

Β 

Following this transaction, the EBT is interested in a total of 676,129 Ordinary Shares, representing approximately 0.27 per cent of the Company's total voting rights.

Β 

Β 

Enquiries:

Β 

Shiv Sibal, Company Secretary

Marshalls plc

+44 (0)1422 314767

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Marshalls EBT Limited

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

PCA -Chief Financial Officer (Justin Lockwood) in his capacity as a director of Marshalls EBT Limited, which is the Trustee of The Marshalls plc Employee Benefit Trust.

Β 

Β 

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Marshalls plc

b)

Β 

LEI

Β 

Β 

213800S21IFC367J5V62

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary Shares

Β 

Β 

GB00B012BV22

b)

Β 

Nature of the transaction

Β 

Β 

Purchase of shares to satisfy the vesting of share options under the Marshalls plc Management Incentive Plan ("MIP") and the Marshalls plc Bonus Share Plan ("BSP")

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β 

151 pence

Β 

Β 

547,000

Β 

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

N/A (single transaction)

Β 

Β 

N/A (single transaction)

Β 

Β 

N/A (single transaction)

Β 

e)

Β 

Date of the transaction

Β 

Β 

02/07/2026

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange, Main Market (XLON)

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHEASXKEDNKEFA
Date   Source Headline
6th Oct 20233:39 pmRNSHolding(s) in Company
4th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:08 pmRNSHolding(s) in Company
17th Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSDirector/PDMR Shareholding
16th Aug 20237:00 amRNSHalf-year Report
2nd Aug 20238:49 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSTrading Statement
21st Jul 202311:25 amRNSDirector Declaration
19th Jul 202312:09 pmRNSDirector Declaration
13th Jul 20234:44 pmRNSDirector/PDMR Shareholding
13th Jul 20234:42 pmRNSDirector/PDMR Shareholding
13th Jul 20234:40 pmRNSDirector/PDMR Shareholding
26th Jun 20234:45 pmRNSDirector/PDMR Shareholding
26th Jun 20234:42 pmRNSDirector/PDMR Shareholding
21st Jun 20232:13 pmRNSHolding(s) in Company
25th May 20233:05 pmRNSHolding(s) in Company
12th May 20239:13 amRNSHolding(s) in Company
10th May 20234:48 pmRNSResult of AGM
10th May 202312:53 pmRNSResult of AGM
9th May 20231:06 pmRNSDirector/PDMR Shareholding
9th May 202312:31 pmRNSDirector/PDMR Shareholding
9th May 202310:34 amRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSTrading Statement
4th Apr 20238:57 amRNSAnnual Financial Report
29th Mar 202312:19 pmRNSEBT Share Purchase
20th Mar 20235:25 pmRNSDirector/PDMR Shareholding
17th Mar 20232:00 pmRNSHolding(s) in Company
17th Mar 20231:46 pmRNSDirector/PDMR Shareholding
17th Mar 202311:18 amRNSDirector/PDMR Shareholding
17th Mar 202311:17 amRNSDirector/PDMR Shareholding
17th Mar 20239:08 amRNSDirector/PDMR Shareholding
16th Mar 20232:49 pmRNSDirector/PDMR Shareholding
15th Mar 20232:45 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSFinal Results
10th Mar 20239:04 amRNSHolding(s) in Company
20th Feb 202310:42 amRNSHolding(s) in Company
16th Feb 202311:42 amRNSHolding(s) in Company
6th Feb 202311:23 amRNSHolding(s) in Company
3rd Feb 202312:51 pmRNSHolding(s) in Company
1st Feb 20232:21 pmRNSDirector/PDMR Shareholding
27th Jan 20231:32 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSTrading Statement
13th Jan 20231:55 pmRNSHolding(s) in Company
8th Nov 20222:12 pmRNSDirectorate Change
8th Nov 202212:01 pmRNSHolding(s) in Company
25th Oct 20224:27 pmRNSHolding(s) in Company
7th Oct 20223:36 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTrading Statement
22nd Sep 20227:00 amRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.